Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
MEDIUM RISK
Score updated Oct 13, 2026

KPRX — Kiora Pharmaceuticals, Inc. Dilution Risk Tracker

Track KPRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KPRX — Get alerts when the score changes →

As of October 13, 2026, Kiora Pharmaceuticals, Inc. (KPRX) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. Kiora Pharmaceuticals, Inc. has a market capitalization of $11.33M, 4.42M shares outstanding, 17 institutional holders tracked. Stored dilution-related fields include 1.28M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰Cash Runway—
📊 Float Risk
22
⚠️ Warrant Exposure
70
🔄 Convertible Debt
40

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 20%
📜 Warrant Exercise model 40%
• Significant warrants: 29% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track KPRX — Get forecast alerts →

Market Data

Market Cap$11.33M
Shares Outstanding4.42M
Float4.30M
Cash$16.84M
Debt$278.2K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding4.42MVerified float table or market cache
Public Float4.30MVerified float table or market cache
Market Cap$11.33MMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.28MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 59.0% shares (2026Q1 vs prior)
17 institutional holders · 359.0K shares
#1 ADAR1 Capital Management, LLC 167.9K shares
#2 CITADEL ADVISORS LLC 49.5K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 47.9K shares
+ 14 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.4K
Days to Cover1.0
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-25
xbrl XBRL CONVERTIBLE 2025-03-25
8-K 8K EVENT 2026-04-07
4 INSIDER TRANSACTION 2026-04-02
4 INSIDER TRANSACTION 2026-04-02
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual KPRX Dilution Snapshot

Kiora Pharmaceuticals, Inc. (KPRX) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

KPRX's DilutionScore is currently 43/100 (Medium risk), with 1 score change tracked over 89 days. The score deteriorated from 47/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202643/100MEDIUM13 days
Jul 16 – Sep 30, 202647/100MEDIUM76 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

KPRX shares outstanding have increased 20.5% from 3.68M (Mar 2026) to 4.43M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 20264.43M4.30M▲ 12.18%
Apr 11, 20263.95M3.83M▲ 0.35%
Apr 07, 20263.95M3.82M▲ 0.10%
Mar 31, 20263.76M3.81M▲ 0.28%
Mar 29, 20263.68M3.80M▲ 5.02%
Mar 26, 20263.68M3.62M▲ 2.56%
Mar 13, 20263.68M3.53M▼ 0.84%
Mar 09, 20263.68M3.56M▲ 0.01%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track KPRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment KPRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking KPRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KPRX
KPRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.